BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1687002)

  • 1. Histamine and histamine type-2 receptor antagonists in psoriasis. Mechanisms and speculations.
    Nielsen HJ
    Dan Med Bull; 1991 Dec; 38(6):478-80. PubMed ID: 1687002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of histamine in pathogenesis of autoimmune diseases: implications for immunotherapy with histamine-2 receptor antagonists.
    Nielsen HJ; Hammer JH
    Med Hypotheses; 1992 Dec; 39(4):349-55. PubMed ID: 1362972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine or ranitidine in renal transplant patients receiving cyclosporine.
    Barri YM; Ramos EL; Balagtas RS; Peterson JC; Karlix JL
    Clin Transplant; 1996 Feb; 10(1 Pt 1):34-8. PubMed ID: 8652895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
    Aydin F; Canturk T; Senturk N; Turanli AY
    Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [H2 antagonists and the heart].
    Corradini P; Zocchi M; Buonavia A
    Minerva Med; 1986 Dec; 77(47-48):2209-15. PubMed ID: 2880317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [H2-antagonists and possibilities for their therapeutic use in dermatology].
    Diller G; Orfanos CE
    Hautarzt; 1982 Oct; 33(10):521-8. PubMed ID: 6130053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ; Stables R
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical effect of ranitidine in psoriasis. An open prospective study].
    Nielsen HJ; Kristensen JK; Hansen U; Nielsen HI; Skov PS; Petersen LM
    Ugeskr Laeger; 1997 Jan; 159(5):598-600. PubMed ID: 9045450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of histamine H2 receptor agonist, antagonist and antineoplastic agent on the in vitro growth of PB CFU-GM from normal individuals and HL-60 leukemia cells].
    He Q; Xu YH
    Yao Xue Xue Bao; 1996; 31(5):340-5. PubMed ID: 9275711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine: what clinicians need to know.
    Koo J; Lee J
    Dermatol Clin; 1995 Oct; 13(4):897-907. PubMed ID: 8785893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of histamine, H1- and H2-receptor antagonists on the activity of serotonergic neurons in the dorsal raphe nucleus.
    Lakoski JM; Aghajanian GK
    J Pharmacol Exp Ther; 1983 Nov; 227(2):517-23. PubMed ID: 6138428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the efficacy of two H2 antagonists of histamine in allergic rhinitis. Considerations on the mechanism of action].
    Mesolella C; Campagnano N; Maione A; Testa B
    Ann Otolaryngol Chir Cervicofac; 1988; 105(3):199-202. PubMed ID: 2899413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of histamine H2-receptor antagonists on hemopoietic reconstruction in bone marrow].
    Du XX; Zhou YJ; Xu YH
    Sheng Li Xue Bao; 1989 Dec; 41(6):597-601. PubMed ID: 2576333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of histamine 2 receptor antagonists on endothelial-neutrophil adhesion and surface expression of endothelial adhesion molecules induced by high glucose levels.
    Takeuchi Y; Okayama N; Imaeda K; Okouchi M; Omi H; Imai S; Akao M; Takeda Y; Hukutomi T; Itoh M
    J Diabetes Complications; 2007; 21(1):50-5. PubMed ID: 17189874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on mast cells and histamine release in psoriasis: the effect of ranitidine.
    Petersen LJ; Hansen U; Kristensen JK; Nielsen H; Skov PS; Nielsen HJ
    Acta Derm Venereol; 1998 May; 78(3):190-3. PubMed ID: 9602224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological properties of histamine receptor subtypes.
    Arrang JM
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):275-81. PubMed ID: 7920174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No significant difference in neutrophil activation found among three H2RAs.
    Fukuda M; Shirasaka D; Aoyama N; Miki I; Kachi M; Morita Y; Tamura T; Kasuga M
    Dig Liver Dis; 2007 Feb; 39(2):130-5. PubMed ID: 17161670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics in combination with nonbiologics: efficacy and safety.
    Stebbins WG; Lebwohl MG
    Dermatol Ther; 2004; 17(5):432-40. PubMed ID: 15379778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.